Long-term follow-up of DDDR closed-loop cardiac pacing for the prevention of recurrent vasovagal syncope

Journal of Cardiovascular Medicine

Volumn 13, Issue 4, 2012, Pages 242-245

  Bortnik, Miriam ^a   Occhetta, Eraldo ^a   Dell'Era, Gabriele ^a   Secco, Gioel G ^a   Degiovanni, Anna ^a   Plebani, Laura ^a   Marino, Paolo ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

cardiac pacing; closed loop stimulation; neurocardiogenic; vasovagal syncope

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL ARTICLE; CLOSED LOOP CARDIAC PACING; CONSCIOUSNESS DISORDER; FEMALE; FOLLOW UP; HEART PACING; HUMAN; MALE; PRESYNCOPE; QUALITY OF LIFE; RECURRENT DISEASE; SYNCOPE;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC PACING, ARTIFICIAL; EQUIPMENT DESIGN; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; QUALITY OF LIFE; RECURRENCE; SYNCOPE, VASOVAGAL; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84858758079     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328351daf5     Document Type: Article

References (12)

1. Brignole M, Menozzi C, Bartoletti A, et al. A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J 2006; 27:76-82. (Pubitemid 41785935)
2. Disertori M, Brignole M, Menozzi C, et al. Management of patients with syncope referred urgently to general hospitals. Europace 2003; 5:283-291. (Pubitemid 36927296)
3. Quan KJ, Carlson MD, Thames MD. Mechanisms of heart rate and arterial blood pressure control: implications for the pathophysiology of neurocardiogenic syncope. Pacing Clin Electrophysiol 1997; 20:764-774.
4. Occhetta E, Bortnik M, Paffoni P, et al. Neurohumoral effects on closed loop stimulation. In: Santini M, editor. Seventh International Symposium on Progress in Clinical Pacing. Rome: CEPI; 1998; pp. 39-43.
5. Occhetta E, Bortnik M, Vassanelli C. The DDDR closed loop stimulation for the prevention of vasovagal syncope: results from the INVASY prospective feasibility registry. Europace 2003; 5:153-162. (Pubitemid 36372373)
6. Occhetta E, Bortnik M, Audoglio R, Vassanelli C, Invasy Study Investigators. Closed loop stimulation in prevention of vasovagal syncope. Inotropy controlled pacing in vasovagal syncope (INVASY): A multicentre randomized, single blind, controlled study. Europace 2004; 6:538-547. (Pubitemid 40378697)
7. Kanjwal K, Karabin B, Kanjwal Y, Grubb BP. Preliminary observation on the use of closed-loop cardiac pacing in patients with refractory neurocardiogenic syncope. J Interv Card Electrophysiol 2010; 27:69-73.
8. Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33:16-20. (Pubitemid 29064066)
9. Sutton R, Brignole M, Menozzi C, et al., The Vasovagal Syncope International study (VASIS) Investigators. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope; pacemaker versus no therapy: A multicoated randomised study. Circulation 2000; 102:294-299. (Pubitemid 30457579)
10. Connolly SJ, Sheldon R, Thorpe KE, et al. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope. Second Vasovagal Pacemaker Study (VPS II): A randomized trial. JAMA 2003; 289:2224-2229. (Pubitemid 37430190)
11. Ravazzi AP, Carosio G, Diotallevi P. Clinical assessment of the correlation between right ventricle impedance and left ventricular contractility. Prog Biomed Res 2000; 5:478-481.
12. Griesbach L, Huber T, Knote B, et al. Closed loop stimulation: Therapy for malignant neurocardiogenic syncope. Prog Biomed Res 2002; 7:242e7.